{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:19:38Z","timestamp":1785860378371,"version":"3.56.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This meta-analysis aims to evaluate the effects of Runzao Zhiyang capsules (RZC) plus antihistamines (AHs) for chronic eczema.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A search involving 8 databases were conducted to collect studies on RZC with AHs for chronic eczema from inception to July 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Thirty-two studies with 3071 participants were identified in this meta-analysis. Compared to the AHs group, the total effective rate of the RZC group was higher (relative risk [RR]\u2005=\u20051.30, 95% confidence interval [CI]\u2005=\u20051.24\u20131.36,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001) and a lower recurrence rate (RR\u2005=\u20050.33, 95% CI\u2005=\u20050.21\u20130.51,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). The RZC group demonstrated better outcomes in the Eczema Area and Severity Index (mean difference [MD]\u2005=\u2005\u22121.44, 95% CI\u2005=\u2005\u22122.18 to \u22120.70,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), severity of pruritus (MD\u2005=\u2005-0.24, 95% CI\u2005=\u2005\u22120.32 to \u22120.15,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), and serum total IgE level (MD\u2005=\u2005\u221218.80, 95% CI\u2005=\u2005\u221225.20 to \u221212.40,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). With respect to safety, the RZC group exhibited a reduced incidence of drowsiness (RR\u2005=\u20050.50, 95% CI\u2005=\u20050.28\u20130.87,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.01), while the incidences of headache, dizziness, and gastrointestinal discomfort did not differ significantly from the AHs group (RR\u2005=\u20050.93, 95% CI\u2005=\u20050.46\u20131.90,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.85); (RR\u2005=\u20051.41, 95% CI\u2005=\u20050.71\u20132.79,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.32).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>RZC when added to conventional AHs, further enhance the treatment efficacy for chronic eczema and significantly reduce the incidence of drowsiness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046334","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T21:02:07Z","timestamp":1766782927000},"page":"e46334","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of Runzao Zhiyang capsules combined with antihistamines in the treatment of chronic eczema: A meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Baihui","family":"Shan","sequence":"first","affiliation":[{"name":"Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Second Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Changchun Maternity Hospital, Changchun, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4242-0672","authenticated-orcid":false,"given":"Junjun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Second Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251226","article-title":"Atopic dermatitis.","volume":"8","author":"K","year":"2024","journal-title":"Ind Sci J Res Eng Manage"},{"key":"R2-20251226","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/17557380241257151","article-title":"Childhood eczema.","volume":"17","author":"Polly","year":"2024","journal-title":"InnovAiT"},{"key":"R3-20251226","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2022.04.061","article-title":"Longitudinal course and predictors of depressive symptoms in atopic dermatitis.","volume":"87","author":"Chatrath","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R4-20251226","doi-asserted-by":"crossref","first-page":"177","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20241721","article-title":"A clinico-epidemiological study of eczematous dermatoses in the geriatric population in a tertiary care hospital.","volume":"10","author":"Farhat","year":"2024","journal-title":"Int J Res Dermatol"},{"key":"R5-20251226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jdin.2023.02.008","article-title":"Pediatric chronic hand eczema: epidemiology, clinical presentation, and management.","volume":"11","author":"Haft","year":"2023","journal-title":"JAAD Int"},{"key":"R6-20251226","first-page":"84","article-title":"Evaluation of clinical diagnostic criteria of atopic dermatitis and serum IGE levels in patients with chronic eczema.","volume":"5","author":"Agrawal","year":"2015","journal-title":"Int J Health Sci Res"},{"key":"R7-20251226","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/CM9.0000000000002560","article-title":"Prevalence and risk factors of atopic dermatitis in Chinese adults: a nationwide population-based cross-sectional study.","volume":"136","author":"Jinning","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R8-20251226","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cea.14302","article-title":"Global trends in eczema prevalence during early life.","volume":"53","author":"Robert","year":"2023","journal-title":"Clin Exp Aller"},{"key":"R9-20251226","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.3390\/ijms25105375","article-title":"Recent advances in phytochemical-based topical applications for the management of eczema: A review.","volume":"25","author":"Radhakrishnan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R10-20251226","first-page":"133","article-title":"The clinical application guidelines for traditional Chinese medicine in the treatment of eczema (2020).","volume":"41","author":"Li","year":"2021","journal-title":"Chin J Int Trad Western Med"},{"key":"R11-20251226","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2017.12.077","article-title":"An assessment of the use of antihistamines in the management of atopic dermatitis.","volume":"79","author":"Alice","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R12-20251226","first-page":"CD012167","article-title":"Oral H1 antihistamines as \u2018add-on\u2019 therapy to topical treatment for eczema.","volume":"1","author":"Matterne","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20251226","first-page":"7","article-title":"Efficacy and safety of modern second-generation antihistamines.","volume":"1","author":"K","year":"2023","journal-title":"Glavvra\u010d (Chief Medical Officer)"},{"key":"R14-20251226","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/ijpd.ijpd_124_21","article-title":"Antihistamines in children: a dermatological perspective.","volume":"23","author":"Sakshi","year":"2022","journal-title":"Ind J Paediatric Dermatol"},{"key":"R15-20251226","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13223-021-00555-0","article-title":"Improvement of skin lesions in corticosteroid withdrawal-associated severe eczema by multicomponent traditional Chinese medicine therapy.","volume":"17","author":"Uzun","year":"2021","journal-title":"Aller Asthma Clin Immunol"},{"key":"R16-20251226","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.anai.2020.12.002","article-title":"Traditional Chinese medicine for food allergy and eczema.","volume":"126","author":"Wang","year":"2021","journal-title":"Annal Aller Asthma Immunol"},{"key":"R18-20251226","first-page":"232","article-title":"Observation of the efficacy of Runzao Zhiyang capsules in treating skin itchiness.","volume":"8","author":"Pan","year":"2009","journal-title":"Chin J Dermatovenerol Int Trad Western Med"},{"key":"R19-20251226","first-page":"39","article-title":"Study on the efficacy of Runzao Zhiyang capsules combined with different medications in the treatment of pruritic skin diseases.","volume":"26","author":"Liu","year":"2009","journal-title":"Med Res Educ"},{"key":"R20-20251226","first-page":"144","article-title":"Study on the efficacy of Runzao Zhiyang capsules in treating chronic eczema.","volume":"7","author":"Pu","year":"2016","journal-title":"China Health Standard Manage"},{"key":"R21-20251226","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R22-20251226","first-page":"681","article-title":"The effect of Ebastine capsules combined with Runzao Zhiyang capsules on serum inflammatory factors and IgE in patients with chronic eczema.","volume":"40","author":"Chang","year":"2018","journal-title":"J Dermatol Venereol"},{"key":"R23-20251226","first-page":"42","article-title":"The effect of Runzao Zhiyang capsules as an adjunctive treatment for chronic eczema.","volume":"41","author":"Chen","year":"2022","journal-title":"Nei Mongol J Trad Chin Med"},{"key":"R24-20251226","first-page":"225","article-title":"The therapeutic efect of Runzao Zhiyang capsule combined withmizolastine sustained-release tablets in the treatment of chronic eczema.","volume":"8","author":"Guan","year":"2016","journal-title":"China Continuing Med Educ"},{"key":"R25-20251226","first-page":"151","article-title":"The clinical efficacy of Runzao Zhiyang capsules combined with mizolastine sustained-release tablets in the treatment of chronic eczema.","volume":"12","author":"Guo","year":"2017","journal-title":"China Pract Med"},{"key":"R26-20251226","first-page":"136","article-title":"Analysis of the efficacy of Runzao Zhiyang capsules in the treatment of chronic eczema.","volume":"42","author":"He","year":"2023","journal-title":"Nei Mongol J Trad Chin Med"},{"key":"R27-20251226","first-page":"43","article-title":"Clinical observation of Runzao Zhiyang capsules combined with loratadine in the treatment of chronic eczema.","volume":"24","author":"He","year":"2024","journal-title":"Pract Clin J Int Trad Chin Western Med"},{"key":"R28-20251226","first-page":"88","article-title":"Clinical efficacy of Runzao Zhiyang capsules combined with loratadine in the treatment of chronic eczema.","volume":"14","author":"Ke","year":"2019","journal-title":"China J Pharmaceutical Econ"},{"key":"R29-20251226","first-page":"58","article-title":"The effect of Ebastine combined with Runzao Zhiyang capsules on patients with chronic eczema.","volume":"21","author":"Li","year":"2021","journal-title":"Pract Clin J Int Trad Chin Western Med"},{"key":"R30-20251226","first-page":"1447","article-title":"Effect of Runzao Zhiyang capsule combined with loratadine onstress response and inflammatory response in chronic eczema.","volume":"39","author":"Li","year":"2018","journal-title":"Shaanxi J Trad Chin Med"},{"key":"R31-20251226","first-page":"86","article-title":"Clinical observation on treating chronic eczema with cetirizine tablets plus the Runzao Zhiyang capsule.","volume":"6","author":"Liu","year":"2014","journal-title":"Clin J Chin Med"},{"key":"R32-20251226","first-page":"387","article-title":"The observation of the efcacy on treating chronic eczema with Runzao Zhiyang capsules and levocetririzine.","author":"Liu","year":"2008","journal-title":"Chin J Dermatovenereol"},{"key":"R33-20251226","first-page":"1173","article-title":"Clinical efficacy and life quality of Runzao Zhiyang capsule and ebastine tablets combined withinterferon gel in the treatment of chronic eezema.","volume":"38","author":"Liu","year":"2018","journal-title":"J Trad Chin Med Univ Hunan"},{"key":"R34-20251226","first-page":"2765","article-title":"Effect of Runzao Zhiyang capsule combined with loratadine tablet and butyl fluofenamate ointment in treatment of chronic eczema and its influence on quality of life.","volume":"37","author":"Liu","year":"2019","journal-title":"Chin Arch Trad Chin Med"},{"key":"R35-20251226","first-page":"230","article-title":"Application value of Runzao Zhiyang capsule in the treatment of eczema.","volume":"21","author":"Meng","year":"2021","journal-title":"World Latest Med Inform"},{"key":"R36-20251226","first-page":"895","article-title":"Observation on the efficacy of Runzao Zhiyang capsules combined with ebastine in the treatment of scrotal eczema.","volume":"27","author":"Qian","year":"2011","journal-title":"China J Leprosy Skin Diseases"},{"key":"R37-20251226","first-page":"58","article-title":"Observation of the efficacy of Runzao Zhiyang capsules combined with loratadine in the treatment of chronic eczema.","volume":"9","author":"Shi","year":"2016","journal-title":"Chin J Clin Rat Drug Use"},{"key":"R38-20251226","first-page":"3390","article-title":"Effect of Runzao Zhiyang capsules combined with ebastine on the treatment of chronic eczema and its impact on peripheral blood EOS and serum IgE levels.","volume":"25","author":"Song","year":"2016","journal-title":"Modern J Int Trad Chin Western Med"},{"key":"R39-20251226","first-page":"1008","article-title":"Observation of Runzao Zhiyang capsule combined with epinastine capsule is effective in the treatment of chronic eczema.","volume":"36","author":"Wang","year":"2015","journal-title":"Sichuan Med J"},{"key":"R40-20251226","first-page":"103","article-title":"Clinical effect of Runzao Zhiyang capsule on patients with chronic eczema.","volume":"23","author":"Wang","year":"2017","journal-title":"Guiding J Trad Chin Med Pharmacol"},{"key":"R41-20251226","first-page":"52","article-title":"Analysis of the therapeutic value of Runzao Zhiyang capsules combined with mizolastine sustained-release tablets in the treatment of chronic eczema.","volume":"28","author":"Wu","year":"2019","journal-title":"J Med Aesthetice Cosmetol"},{"key":"R42-20251226","first-page":"32","article-title":"Analysis of the efficacy of Runzao Zhiyang capsules in the treatment of chronic eczema.","volume":"15","author":"Xing","year":"2016","journal-title":"Health Way"},{"key":"R43-20251226","first-page":"609","article-title":"Clinical research of Runzao Zhiyang capsule combined with mizolastine to treat chronic eczema.","volume":"23","author":"Yang","year":"2009","journal-title":"Chin J Dermatovenereol"},{"key":"R44-20251226","first-page":"153","article-title":"Clinical effect analysis of moistening dryness and relieving itching capsule in adjuvant treatment of eczema.","volume":"7","author":"Yao","year":"2021","journal-title":"Smart Healthcare"},{"key":"R45-20251226","first-page":"45","article-title":"The effect of Runzao Zhiyang Capsules on the treatment of chronic eczema and its influence on the level of EOS and serum IgE in peripheral blood.","volume":"25","author":"Zhang","year":"2018","journal-title":"China Modern Med"},{"key":"R46-20251226","first-page":"151","article-title":"Effects of Runzao Zhiyang capsule combined with desloratadine citrate on clinical efficacy and inflammatory factors of chronic eczema.","volume":"8","author":"Zhang","year":"2023","journal-title":"Syst Med"},{"key":"R47-20251226","first-page":"88","article-title":"Effectiveness analysis of chronic eczema treatment.","volume":"22","author":"Zhang","year":"2022","journal-title":"World Latest Med Inform"},{"key":"R48-20251226","first-page":"177","article-title":"Observation of the efficacy of Runzao Zhiyang capsules in treating chronic eczema.","volume":"13","author":"Zhao","year":"2011","journal-title":"Chin Commun Doctors"},{"key":"R49-20251226","first-page":"47","article-title":"Observation on the efficacy of Runzao Zhiyang capsules combined with ebastine in the treatment of chronic eczema.","volume":"7","author":"Zheng","year":"2012","journal-title":"Nat Med Front China"},{"key":"R50-20251226","first-page":"32","article-title":"Effects of Runzao Zhiyang capsule combined with ebastine tablets and calamine lotion on patients with chronic eczema.","volume":"20","author":"Zhou","year":"2022","journal-title":"Chin Foreign Med Res"},{"key":"R51-20251226","first-page":"98","article-title":"Application effect of Runzao Zhiyang capsule and mizolastine sustained release tablets in the clinical treatment of chronic eczema.","volume":"5","author":"Zhu","year":"2020","journal-title":"DOCTOR"},{"key":"R52-20251226","first-page":"136","article-title":"Clinical efficacy observation of Runzao Zhiyang capsules combined with antiallergic drugs in the treatment of 120 cases of chronic eczema.","volume":"19","author":"Zhu","year":"2019","journal-title":"World Latest Med Inform"},{"key":"R53-20251226","first-page":"572","article-title":"Network pharmacology combined with animal experiment to explore the mechanism of action of Runzao Zhiyang capsule in treating eczema.","volume":"41","author":"Huiying","year":"2023","journal-title":"Chin J Clin Anatomy"},{"key":"R54-20251226","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/09546634.2019.1571267","article-title":"Efficacy and safety of Run Zao Zhi Yang capsule on chronic eczema: a multiple-center, randomized, double-blind, placebo-controlled clinical study.","volume":"30","author":"Huang","year":"2019","journal-title":"J Dermatol Treatment"},{"key":"R55-20251226","first-page":"1564","article-title":"Themodern research progress of Traditional Chinese Medicine in the treatment of eczema.","volume":"40","author":"Li","year":"2023","journal-title":"J Shenyang Pharmaceut Univ"},{"key":"R56-20251226","doi-asserted-by":"crossref","first-page":"927304","DOI":"10.3389\/fphar.2022.927304","article-title":"Efficacy and safety of Chinese herbal medicine for atopic dermatitis: Evidence from eight high-quality randomized placebo-controlled trials.","volume":"13","author":"Cai","year":"2022","journal-title":"Front Pharmacol"},{"key":"R57-20251226","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/13651501.2014.907919","article-title":"Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety.","volume":"18","author":"Ozdemir","year":"2014","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R58-20251226","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1248\/yakushi.16-00237-2","article-title":"Patients taking antihistamines and their effects on driving.","volume":"137","author":"Kizu","year":"2017","journal-title":"Yakugaku Zasshi"},{"key":"R59-20251226","first-page":"994","article-title":"UHPLC-Q-Exactive Plus HRMS analysis of chemical composition of moisturizing and itching-relieving capsules.","volume":"50","author":"Chen","year":"2025","journal-title":"J Guizhou Med Univ"},{"key":"R60-20251226","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1939-4551-1-9-145","article-title":"H1 Antihistamines: current status and future directions.","volume":"1","author":"Simon","year":"2008","journal-title":"World Allergy Organ J"},{"key":"R61-20251226","first-page":"6693268","article-title":"Efficacy and safety of Runzao Zhiyang capsule as an add-on therapy for chronic eczema: A systematic review and meta-analysis.","volume":"2021","author":"Ming","year":"2021","journal-title":"Evidence-based Complementary Alternative Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:24:24Z","timestamp":1785857064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":60,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046334","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"2024-09-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}